This federal contract award is for the provision of Oxford Nanopore long read sequencing kits to the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH). The $550,333 firm-fixed-price purchase order was awarded to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company specializing in nanopore-based sequencing technologies. The contract does not have a set-aside designation.
The contract was awarded to administratively de-obligate unexpended and expiring fiscal year 2020 funding in preparation for the September 30, 2025 closing of the period of availability for these funds. Oxford Nanopore Technologies Inc. is a provider of advanced genomic sequencing equipment, consumables, reagents, software, and associated services to various federal agencies, including the NIH, Centers for Disease Control and Prevention, U.S. Department of Agriculture, Department of Defense, and Food and Drug Administration. This specific award supports the NIA's long read sequencing research on neurodegenerative diseases.